According to OSE Immunotherapeutics's latest financial reports the company's current earnings (TTM) are -$25.67 M. In 2023 the company made an earning of -$25.67 M a decrease over its 2022 earnings that were of -$19.34 M.The earnings displayed on this page is the company's Pretax Income.